NewsBreast cancer-on-a-chip for testing immunotherapy
drugs

2nd February 2021by admin0
https://nfusion-tech.com/wp-content/uploads/2021/02/breast-cancer-on-a-chip-for-testing-immunotherapydrugs_601a73927ffbc.jpeg

There are many mechanisms by which the body responds
to foreign invaders. One of these involves the T-cells of the
immune system, which have a number of different proteins on their
surface called ‘checkpoint proteins.’ These checkpoint proteins
bind to proteins on the surface of other cells and can result in
either stimulation or suppression of T-cell activity. Normally,
surface proteins on foreign or invading cells will produce a
stimulation of T-cell activity against these cells, while T-cell
suppression is a built-in mechanism to prevent the immune system
from attacking the body’s own normal cells.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2021 New Fusion All Rights Reserved

      Designed by FallingBrick